Actual Medicinal Product (AMP) Provera 5mg tablets (Necessity Supplies Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from moisture. No stability data in MCAs available.

Provenance

This recommendation is based on the products Provera 5mg tablets (Pfizer Ltd) and Medroxyprogesterone acetate 5mg tablets (Pfizer Ltd).

Generic
Medroxyprogesterone
Formulation
Medroxyprogesterone 5mg tablets
  • Medroxyprogesterone
    • Medroxyprogesterone 5mg tablets

      • Provera 5mg tablets (Necessity Supplies Ltd)